Back
Aclaris Therapeutics Stock Price Chart
This trade could move overnight Thursday!
Access my free presentation on these overnight trades right here
Sell
26
ACRS
Aclaris Therapeutics
Last Price:
1.25
Seasonality Move:
-2.56%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.- The current trend is relatively stagnant and ACRS is experiencing slight selling pressure.
Aclaris Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Buy |
| 20-day SMA: | 1.21 | Buy |
| 50-day SMA: | 1.22 | Buy |
| 200-day SMA: | 4.05 | Sell |
| 8-day EMA: | 1.22 | Buy |
| 20-day EMA: | 1.21 | Buy |
| 50-day EMA: | 1.27 | Sell |
| 200-day EMA: | 3.78 | Sell |
Aclaris Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 52.33 | Buy |
| Chaikin Money Flow: | -126508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.24) | Buy |
| Bollinger Bands (100): | (1.02 - 1.26) | Buy |
Aclaris Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics Stock
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 1.23 while ACRS 8-day simple moving average is 1.21, which is a Buy signal.
- The stock price of ACRS is 1.23 while Aclaris Therapeutics 20-day SMA is 1.21, which makes it a Buy.
- Aclaris Therapeutics 50-day simple moving average is 1.22 while ACRS share price is 1.23, making it a Buy technically.
- ACRS stock price is 1.23 and Aclaris Therapeutics 200-day simple moving average is 4.05, creating a Sell signal.
ACRS Technical Analysis vs Fundamental Analysis
Sell
26
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a Sell
The current Aclaris Therapeutics [ACRS] share price is $1.23. The Score for ACRS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Aclaris Therapeutics Stock Info
Market Cap:
87.24M
Price in USD:
1.23
Share Volume:
632.54K
Aclaris Therapeutics 52-Week Range
52-Week High:
11.12
52-Week Low:
0.59
Sell
26
Aclaris Therapeutics (ACRS)
is a Sell
Aclaris Therapeutics Share Price Forecast
-
What is the Aclaris Therapeutics stock price today?
The Aclaris Therapeutics stock price is 1.23 USD today. -
Will ACRS stock go up or go down?
Aclaris Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aclaris Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics is overvalued.
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 1.23 while ACRS 8-day exponential moving average is 1.22, which is a Buy signal.
- The stock price of ACRS is 1.23 while Aclaris Therapeutics 20-day EMA is 1.21, which makes it a Buy.
- Aclaris Therapeutics 50-day exponential moving average is 1.27 while ACRS share price is 1.23, making it a Sell technically.
- ACRS stock price is 1.23 and Aclaris Therapeutics 200-day simple moving average is 3.78, creating a Sell signal.
Fundamental Analysis of Aclaris Therapeutics
Is Aclaris Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Technical Analysis of Aclaris Therapeutics
Should I short Aclaris Therapeutics stock?
- ACRS Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Aclaris Therapeutics is a Buy
- Aclaris Therapeutics Relative Strength Index (RSI) is 52.33, which suggest Aclaris Therapeutics is overbought
- The Bollinger Bands (25) for Aclaris Therapeutics is (1.16 - 1.24), which suggest Aclaris Therapeutics is a Buy
- The Bollinger Bands (100) for Aclaris Therapeutics is (1.02 - 1.26), which suggest Aclaris Therapeutics is a Buy
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.